Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamideAmy E. DeZern, Robert A. Brodsky, Philip Imus et al.|Blood Advances|2020Cited by 149
Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow TransplantationPhilip Imus, Javier Bolaños‐Meade, Amanda L. Blackford et al.|Biology of Blood and Marrow Transplantation|2017Cited by 59
Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemiaAmy E. DeZern, Robert A. Brodsky, Marianna Zahurak et al.|Blood|2023Cited by 41
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myelomaRoss S. Greenberg, Philip Imus, Jake A. Ruddy et al.|BMC Cancer|2021Cited by 14